Canagliflozin, a sodium glucose co-transporter 2 inhibitor,...

Canagliflozin, a sodium glucose co-transporter 2 inhibitor, reduces post-meal glucose excursion in patients with type 2 diabetes by a non-renal mechanism: results of a randomized trial

Stein, Peter, Berg, Jolene K., Morrow, Linda, Polidori, David, Artis, Eunice, Rusch, Sarah, Vaccaro, Nicole, Devineni, Damayanthi
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
63
Language:
english
Journal:
Metabolism
DOI:
10.1016/j.metabol.2014.07.003
Date:
October, 2014
File:
PDF, 563 KB
english, 2014
Conversion to is in progress
Conversion to is failed